Jung Hak LIM
2Patents
0h-index
7Co-inventors
24Inventor score
Filing activity: Mar 27, 2019 → Sep 25, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11491208B2 | Sequence-specific in vivo cell targeting | Chemistry; Metallurgy | 0 | Active |
| US11865164B2 | Pharmaceutical composition for treating cancer, containing guide RNA and endonuclease as active ingredients | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.